Influence of Yoga in Patients With Neurocardiogenic Syncope (SYNC - YOGA)

This study has been completed.

Sponsor:

Information provided by (Responsible Party):

Dhanunjaya Lakkireddy, MD, FACC, University of Kansas Medical Center Research Institute

ClinicalTrials.gov Identifier:

NCT01695525

First received: July 5, 2012

Last updated: June 27, 2015

Last verified: June 2015

History of Changes

Purpose

Syncope is a common problem that many clinicians may encounter in various outpatient settings. Neurocardiogenic syncope (NCS) is a benign condition characterized by a self limited episode of systemic hypotension. Patients are usually managed with education on syncope, anxiety management, and coping skills.

It has been established that practice of Yoga could relieve stress and anxiety. In a different study, they also found that Yoga positively influences cardiovascular function by decreasing the heart rate and blood pressure. The main objective of Yoga is to achieve control over the autonomic nervous system and able to control functions like heart rate, blood pressure and respiratory rate.

Based on the findings that Yoga relieves stress and reduces heart rate, the investigators propose to study if Yoga can decrease the frequency of NCS and also reduce the symptoms associated with these episodes.

Condition	Intervention	Phase
Syncope, Vasovagal	Other: Yoga	Early Phase 1


Study Type:	Interventional
Study Design:	Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Neurocardiogenic Syncope and the Role That Yoga Plays in People With Autonomic Dysfunction

Resource links provided by NLM:

MedlinePlus related topics: Fainting

U.S. FDA Resources

Further study details as provided by Dhanunjaya Lakkireddy, MD, FACC, University of Kansas Medical Center Research Institute:

Primary Outcome Measures:

Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) [ Time Frame: Baseline to 3 Months ]
Differences in the incidence of syncopal spells pre and post Yoga.
Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) [ Time Frame: Baseline to 1 Year ]
Differences in the incidence of syncopal spells pre and post Yoga.
Change in frequency of recurrent syncopal spells in patients with Neurocardiogenic syncope (NCS) [ Time Frame: Baseline to 1 Year ]
Differences in the incidence of syncopal symptoms pre and post Yoga.

Secondary Outcome Measures:

Change in Heart Health [ Time Frame: 3 Months, 1 Year ]


Enrollment:	8
Study Start Date:	June 2012
Study Completion Date:	March 2015
Primary Completion Date:	March 2015 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Yoga Participants will be asked to practice Yoga 3 times per week at a minimum, and daily at a maximum. Participants will receive training in different Yoga techniques including breathing exercises, postures and meditation. Participants will be asked to practice 1 hour Yoga sessions comprised of breathing exercises, postures and meditation.	Other: Yoga Includes breathing exercises, postures, and meditation. Participant practices yoga at their home a minimum of 3 times per week for 1 hour per time. Participation can last for up to 1 year.

Eligibility


Ages Eligible for Study:	18 Years to 60 Years (Adult)
Sexes Eligible for Study:	All
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Diagnosis of recurrent Neurocardiogenic syncope
At least one episode of syncope or pre-syncopal event in the last 3 months prior to enrollment

Exclusion Criteria:

Previously established diagnosis of any psychiatric illness.
Previous history of Coronary Artery Disease, myocardial infarction, congestive heart failure, carotid sinus hypersensitivity
Established diagnosis of tachy and/or brady arrhythmias, except cardioinhibiotry neurocardiogenic syncope.
History of pacemaker, ICD or CRT-D implantation.
Other conditions where Yoga should be avoided are:
1. Pregnant women
2. Subjects with untreated or uncontrolled high blood pressure
3. Subjects with past history of Pnuemothorax.
4. Subjects with severe cervical spondylitis and cervical, thoracic or lumbar disc prolapse.
5. Subjects with carotid stenosis
6. Subjects with history of psychosis (evidence of acute episodes with deep and prolonged meditation) or substance abuse.
7. Subjects with the history of epilepsy ( evidence of acute episodes with deep and prolonged meditation)
8. Subjects with glaucoma
9. Subjects with history of Total Hip Replacement.

Contacts and Locations

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01695525

Locations


United States, Kansas
University of Kansas Medical Center
Kansas City, Kansas, United States, 66160

Sponsors and Collaborators

Dhanunjaya Lakkireddy, MD, FACC

Investigators


Principal Investigator:	Dhanunjaya Lakkireddy, MD, FACC	University of Kansas Medical Center

More Information


Responsible Party:	Dhanunjaya Lakkireddy, MD, FACC, Professor of Medicine, University of Kansas Medical Center Research Institute
ClinicalTrials.gov Identifier:	NCT01695525 History of Changes
Other Study ID Numbers:	12945
Study First Received:	July 5, 2012
Last Updated:	June 27, 2015

Keywords provided by Dhanunjaya Lakkireddy, MD, FACC, University of Kansas Medical Center Research Institute:


Neurocardiogenic Syncope Yoga

Additional relevant MeSH terms:


Syncope Syncope, Vasovagal Unconsciousness Consciousness Disorders Neurobehavioral Manifestations Neurologic Manifestations	Nervous System Diseases Signs and Symptoms Orthostatic Intolerance Primary Dysautonomias Autonomic Nervous System Diseases

ClinicalTrials.gov processed this record on July 21, 2017

To Top